Furthermore, overexpression of an active site mutant human DDAH1 does not significantly alter cell behavior or VEGF expression, providing additional evidence that hydrolytic activity of DDAH1 is required for mediation of prostate cancer growth. This evidence concerns the gene VEGFA and prostate carcinoma.